uniQure Pharma - QURE Net earnings per one share for the last twelve months

Official company branding of uniQure Pharma (QURE)

The YoY net income per share growth for uniQure N.V. (QURE) over the last 12 months demonstrates a current level of approximately 18.90. This trend is supported by the implementation of energy-saving technologies in laboratories and strict environmental controls. Matt Kapusta's expert management relies on in-house capacities and partnerships. Business stability is ensured through diversification via royalties and the development of independent therapy programs for neurological pathologies.

uniQure NV - QURE Earnings per share for the last twelve months (period 02/11/2024 - 11/18/2026)

Financial and market metric breakdowns for uniQure N.V. (QURE)

- current price and projected stock value:
Fundamental valuation:QURE (uniQure NV)
Original product of uniQure Pharma

This indicator measures the rate of change in earnings per share (EPS) over a rolling year, reflecting the dynamics of shareholder value generation relative to previous periods. By analyzing the annual EPS growth rate over the last 12 months, investors assess the efficiency of uniQure N.V. (QURE) capital expenditures in high-cost gene therapy development and the ability of innovative treatments for rare diseases to translate into tangible financial results.

Competitor analysis

Earnings per share for the trailing year TEM (Tempus AI Inc)|QGEN (Qiagen Group) - Net earnings per share for the last 12 months|Earnings per one share for the last 12 months IONS (Ionis Pharma)|Earnings per share for the last twelve months Repligen|Earnings per share for the last twelve months RNA|Net earnings per share (EPS TTM) CRSP|Earnings per share for the last twelve months WGS (GeneDx)|Ultragenyx Pharmaceutical - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Beam Tx BEAM|Sarepta Therapeutics - Net earnings per share (EPS TTM)|Twist Bioscience (TWST) - Net earnings per share for the last 12 months|TXG: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Intellia Therapeutics Inc (NTLA)|STOK (stoketherapeutics.com) - Net earnings per share (EPS TTM)|BLFS (BioLife Corp) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Wave Life Sciences Ltd. (WVE)|Earnings per share for the last four quarters MAZE|sionnatx.com - Net earnings per share for the last 12 months|Earnings per share for the trailing year PRME|TSHA - Earnings per share for the last twelve months|Net earnings per share for the trailing year MeiraGTx Corp (MGTX)|REGENXBIO (RGNX) - Earnings per share for the last twelve months|SLDB - Net earnings per share for the last four quarters|OCGN (ocugen.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Pacific Biosciences of California, Inc. PACB|Net earnings per share (EPS TTM) BNTC|Net earnings per share for the last four quarters Design Pharma|Net earnings per share (EPS TTM) RCKT (Rocket Corp)|FDMT - Net earnings per share for the last 12 months|Lexeo - Net earnings per share (EPS TTM)|KRRO - Net earnings per share (EPS TTM)|EDIT: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months SLN|Net earnings per share for the last 12 months PRQR|Net earnings per one share for the last twelve months Codexis CDXS|Earnings per share for the last twelve months Sangamo BioSciences (SGMO)|Net earnings per share (EPS TTM) Nautilus Biotechnology Inc (NAUT)|Net earnings per share (EPS TTM) MGX (Metagenomi Inc.)|Precision BioSciences - Earnings per share for the last twelve months|generationbio.com - Net earnings per share (EPS TTM)|BOLD: Earnings per share for the last twelve months|XCUR (Exicure Corp) - Net earnings per share for the last 12 months|Earnings per share for the last 12 months IMNN|Earnings per share for the last twelve months RXi Pharmaceuticals|Net earnings per share (EPS TTM) mustangbio.com|Net earnings per share (EPS TTM) RNAZ|Earnings per share for the last twelve months BNGO (Bionano Genomics)|Earnings per share for the last twelve months Applied DNA Sciences APDN|Net earnings per share for the last four quarters bluebird bio Inc. (BLUE)|IPA - Earnings per share for the last twelve months|Earnings per share for the trailing year OMGA (Omega Therapeutics)|OMIC: Net earnings per share (EPS TTM)|RGLS (Regulus Therapeutics Inc.) - Earnings per share for the last twelve months|Earnings per share for the last twelve months Syros Pharmaceuticals Inc.|Telesis Bio Inc. (TBIO) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months traconpharma.com (TCON)|Earnings per share for the last four quarters UBX